BIOMAT Database Logo BIOMAT Database Logo

HTLV-III infection in Canada in 1985. 1986

P W Neumann, and B J Benning, and D G Robinson, and N Gilmore, and M V O'Shaughnessy

More than 25 000 serum specimens have been tested for antibody to human T-lymphotropic virus type III (HTLV-III) at the Laboratory Centre for Disease Control, Ottawa, since August 1984. In 1985 the prevalence rates of antibody positivity among selected risk groups were as follows: patients with Kaposi's sarcoma, 77%; patients with acquired immune deficiency syndrome (AIDS) or AIDS-related complex (ARC), 66%; patients with hemophilia, 65%; symptomatic homosexual men, 48%; cohabitants of patients with AIDS, ARC or antibody to HTLV-III, 24%; and intravenous drug abusers, 13%. No case of accidental parenteral exposure has resulted in seroconversion. Eight cases of AIDS, all in antibody-positive patients, have been associated with blood transfusions. A testing protocol based on risk-group information is proposed for diagnostic laboratories.

UI MeSH Term Description Entries
D008297 Male Males
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D002170 Canada The largest country in North America, comprising 10 provinces and three territories. Its capital is Ottawa.
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006716 Homosexuality The sexual attraction or relationship between members of the same SEX. Homosexuality, Ego-Dystonic,Ego-Dystonic Homosexuality,Homosexuality, Ego Dystonic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D015483 HIV Antibodies Antibodies reactive with HIV ANTIGENS. AIDS Antibodies,HIV-Associated Antibodies,HTLV-III Antibodies,HTLV-III-LAV Antibodies,LAV Antibodies,Lymphadenopathy-Associated Antibodies,T-Lymphotropic Virus Type III Antibodies, Human,HIV Associated Antibodies,HTLV III Antibodies,HTLV III LAV Antibodies,Lymphadenopathy Associated Antibodies,T Lymphotropic Virus Type III Antibodies, Human,Antibodies, AIDS,Antibodies, HIV,Antibodies, HIV Associated,Antibodies, HIV-Associated,Antibodies, HTLV III,Antibodies, HTLV-III,Antibodies, HTLV-III-LAV,Antibodies, LAV,Antibodies, Lymphadenopathy Associated,Antibodies, Lymphadenopathy-Associated

Related Publications

P W Neumann, and B J Benning, and D G Robinson, and N Gilmore, and M V O'Shaughnessy
Acute HTLV III infection.
May 1985, The New Zealand medical journal,
P W Neumann, and B J Benning, and D G Robinson, and N Gilmore, and M V O'Shaughnessy
[LAV/HTLV III infection in a group of homosexual and bisexual men in 1983 and 1985].
March 1986, Ugeskrift for laeger,
P W Neumann, and B J Benning, and D G Robinson, and N Gilmore, and M V O'Shaughnessy
[Epidemiologic study of infection by the HTLV-III/LAV agent in Asturian heroin addicts, 1983-1985].
October 1986, Medicina clinica,
P W Neumann, and B J Benning, and D G Robinson, and N Gilmore, and M V O'Shaughnessy
[HTLV-III infection in risk groups].
January 1986, Medicina clinica,
P W Neumann, and B J Benning, and D G Robinson, and N Gilmore, and M V O'Shaughnessy
HTLV-III infection in the RSA.
October 1986, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
P W Neumann, and B J Benning, and D G Robinson, and N Gilmore, and M V O'Shaughnessy
Prevention of HTLV-III infection.
July 1986, JAMA,
P W Neumann, and B J Benning, and D G Robinson, and N Gilmore, and M V O'Shaughnessy
[Hemophilia and HTLV-III infection].
December 1986, Zeitschrift fur Hautkrankheiten,
P W Neumann, and B J Benning, and D G Robinson, and N Gilmore, and M V O'Shaughnessy
[Acute LAV/HTLV III infection].
January 1986, Nordisk medicin,
P W Neumann, and B J Benning, and D G Robinson, and N Gilmore, and M V O'Shaughnessy
HTLV III infection and AIDS.
October 1985, The Practitioner,
P W Neumann, and B J Benning, and D G Robinson, and N Gilmore, and M V O'Shaughnessy
[HTLV-III infection serologic diagnosis].
May 1986, Suomen hammaslaakarilehti = Finlands tandlakartidning,
Copied contents to your clipboard!